Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caffeine | 3 | 2018 | 81 | 1.310 |
Why?
|
| Central Nervous System Stimulants | 3 | 2018 | 216 | 1.140 |
Why?
|
| Isoflurane | 4 | 2019 | 64 | 1.070 |
Why?
|
| Anesthesia, General | 5 | 2023 | 114 | 1.010 |
Why?
|
| Anesthetics, Inhalation | 2 | 2019 | 95 | 0.790 |
Why?
|
| Anesthesia Recovery Period | 2 | 2018 | 56 | 0.780 |
Why?
|
| Anesthesia | 1 | 2021 | 164 | 0.710 |
Why?
|
| Anesthesiology | 1 | 2021 | 157 | 0.690 |
Why?
|
| Citrates | 1 | 2018 | 28 | 0.670 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2017 | 6 | 0.620 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2017 | 13 | 0.610 |
Why?
|
| Anesthetics, General | 2 | 2023 | 11 | 0.390 |
Why?
|
| Dexmedetomidine | 1 | 2023 | 11 | 0.230 |
Why?
|
| Colforsin | 2 | 2017 | 74 | 0.180 |
Why?
|
| Preoperative Care | 1 | 2021 | 394 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1219 | 0.160 |
Why?
|
| RNA | 3 | 2008 | 560 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 399 | 0.150 |
Why?
|
| Triazoles | 1 | 2017 | 96 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 2017 | 273 | 0.140 |
Why?
|
| Rats | 3 | 2019 | 3990 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2019 | 313 | 0.140 |
Why?
|
| Introns | 2 | 2007 | 289 | 0.130 |
Why?
|
| Laryngoscopy | 1 | 2014 | 44 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2017 | 370 | 0.120 |
Why?
|
| RNA Splicing | 2 | 2007 | 142 | 0.120 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1823 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2013 | 41 | 0.120 |
Why?
|
| Propofol | 1 | 2013 | 89 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 246 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 521 | 0.090 |
Why?
|
| Time Factors | 1 | 2018 | 5209 | 0.090 |
Why?
|
| Oligoribonucleotides | 2 | 2007 | 28 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 2 | 2008 | 332 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2014 | 1143 | 0.090 |
Why?
|
| RNA, Catalytic | 2 | 2007 | 129 | 0.080 |
Why?
|
| Pseudouridine | 1 | 2007 | 19 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 2216 | 0.070 |
Why?
|
| Magnesium | 1 | 2007 | 177 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2007 | 105 | 0.070 |
Why?
|
| Adenosine | 1 | 2007 | 225 | 0.060 |
Why?
|
| Solvents | 1 | 2004 | 96 | 0.060 |
Why?
|
| Animals | 3 | 2019 | 26582 | 0.060 |
Why?
|
| Humans | 4 | 2021 | 86617 | 0.060 |
Why?
|
| Water | 1 | 2004 | 277 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 25640 | 0.040 |
Why?
|
| Hydroxyl Radical | 2 | 2008 | 35 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 839 | 0.040 |
Why?
|
| Male | 1 | 2018 | 40958 | 0.030 |
Why?
|
| Catalysis | 2 | 2005 | 203 | 0.030 |
Why?
|
| Theophylline | 1 | 2013 | 34 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2013 | 115 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2008 | 1286 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 894 | 0.030 |
Why?
|
| DNA Ligases | 1 | 2007 | 13 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 49 | 0.020 |
Why?
|
| RNA, Fungal | 1 | 2007 | 42 | 0.020 |
Why?
|
| Sulfur | 1 | 2007 | 28 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2007 | 39 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2894 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 347 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 178 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 450 | 0.020 |
Why?
|
| Metals | 1 | 2005 | 90 | 0.020 |
Why?
|
| Neurons | 1 | 2013 | 1546 | 0.020 |
Why?
|
| Binding Sites | 1 | 2007 | 1098 | 0.020 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2004 | 8 | 0.020 |
Why?
|
| Ribose | 1 | 2004 | 17 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5417 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 485 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 53 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 2330 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 144 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3030 | 0.010 |
Why?
|
| Oxygen | 1 | 2007 | 726 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7990 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 502 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2705 | 0.010 |
Why?
|
| Ethanol | 1 | 2004 | 249 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 1749 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2426 | 0.010 |
Why?
|
| Female | 1 | 2014 | 44509 | 0.010 |
Why?
|